Premier Inc. Class A Aktie News

CHARLOTTE, N.C. & TORRANCE, Calif.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare performance improvement company, today announced that it has entered a five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. (Premier Infusion and HCS). Premier Infusion and HCS is a closed-door infusion pharmacy based in Torrance, Califor...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, has named Bruce Radcliff President of Supply Chain Services.

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Baird Global Healthcare Conference on Tuesday, Sept. 9, 2025 at 8:30 a.m. ET. A link to the live audio webcast, as well as a replay of this event, will be available in the Invest...

Premier, Inc. (NASDAQ:PINC ) Q4 2025 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Ben Krasinski - Director of Investor Relations David P. Zito - President of Performance Services Glenn G.

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 fourth quarter and full year ended June 30, 2025. Fiscal-year 2025 fourth quarter total net revenue of $262.9 million decreased 12% from the prior-year period; however, increased 1% on a sequential basis from the fi...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2025, to stockholders of record as of the close of business on September 1, 2025. Abou...

DALLAS--(BUSINESS WIRE)--AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for sterile, patient-specific intrathecal pain pump medications. In addition, to assist...

Premier offers technology breakthrough designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies Premier offers technology breakthrough designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies